RECRUITING

Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The researchers have worked to create consensus recommendations among national efforts to help with the transition and coordination of care for preterm infants with lung disease around discharge from the neonatal intensive care unit to home. This study looks to evaluate implementation of the recommendations at Boston Children's Hospital and referring NICU's (Beth Israel Deaconess Medical Center and Brigham and Women's Hospital). Specifically, the research team will be looking at follow-up rates, healthcare utilization, and parental satisfaction/feedback with implementation of these guidelines.

Official Title

Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease

Quick Facts

Study Start:2023-09-27
Study Completion:2025-11
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05285345

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Days to 1 Year
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Preterm infants born \<32 weeks with at least mild BPD, defined as 28 days of respiratory support after birth.
  2. * Efforts will be made to include a mix of infants with mild, moderate, and severe BPD, including infants discharged on oxygen.
  1. * Discharge to a location other than home.
  2. * Infants with other congenital disease (cardiac, genetic, neurological) thought to contribute significantly to their respiratory disease.

Contacts and Locations

Study Contact

Jonathan Levin, MD
CONTACT
617-355-1900
jonathan.levin@childrens.harvard.edu
Vanessa J Young
CONTACT
617-355-8330
vanessa.young@childrens.harvard.edu

Principal Investigator

Jonathan Levin, MD
PRINCIPAL_INVESTIGATOR
Boston Children's Hospital

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02115
United States

Collaborators and Investigators

Sponsor: Boston Children's Hospital

  • Jonathan Levin, MD, PRINCIPAL_INVESTIGATOR, Boston Children's Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-27
Study Completion Date2025-11

Study Record Updates

Study Start Date2023-09-27
Study Completion Date2025-11

Terms related to this study

Keywords Provided by Researchers

  • Bronchopulmonary Dysplasia
  • NICU Discharge

Additional Relevant MeSH Terms

  • Bronchopulmonary Dysplasia